Combination Therapy of Albumin-Bound Paclitaxel and Carboplatin as First Line Therapy in a Patient with Ovarian Cancer

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="940591.fig.003a" src="https://static.hindawi.com/articles/crionm/volume-2014/940591/figures/940591.fig.003a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>No evidence of pleural effusion</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="940591.fig.003b" src="https://static.hindawi.com/articles/crionm/volume-2014/940591/figures/940591.fig.003b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>No evidence of mass in abdominopelvis</td></tr></table></td></tr></table>

<table>CT scan after 4 weeks following 6 cycles.</table>

Case Reports in Oncological Medicine

fig3

Figure 3

Figure 3: Combination Therapy of Albumin-Bound Paclitaxel and Carboplatin as First Line Therapy in a Patient with Ovarian Cancer 